An interferon-sensitive response element is involved in constitutive caspase-8 gene expression in neuroblastoma cells

International Journal of Cancer

Volumn 120, Issue 1, 2007, Pages 39-47

  De Ambrosis, Alessandro ^a   Casciano, Ida ^a   Croce, Michela ^a   Pagnan, Gabriella ^b   Radic, Luana ^a   Banelli, Barbara ^a   Di Vinci, Angela ^a   Allemanni, Giorgio ^a   Tonini, Gian Paolo ^a   Ponzoni, Mirco ^b   Romani, Massimo ^a   Ferrini, Silvano ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

Author keywords

Caspase 8; Interferon sensitive response element; Neuroblastoma; Promoter

Indexed keywords

CASPASE 8; COMPLEMENTARY DNA; DNA FRAGMENT; GAMMA INTERFERON; HISTONE; INTERFERON; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 2;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA FLANKING REGION; DNA RESPONSIVE ELEMENT; DNA SEQUENCE; EXON; GENE AMPLIFICATION; GENE DELETION; GENE DISRUPTION; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; RNA INTERFERENCE; SEQUENCE ANALYSIS; TRANSCRIPTION INITIATION SITE;

ANTIVIRAL AGENTS; BASE SEQUENCE; BINDING SITES; CASPASE 8; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERON REGULATORY FACTOR-2; INTERFERON TYPE II; MOLECULAR SEQUENCE DATA; NEUROBLASTOMA; PROMOTER REGIONS (GENETICS); RESPONSE ELEMENTS; RNA, MESSENGER; RNA, SMALL INTERFERING; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 33845398930     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22173     Document Type: Article

References (49)

1. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996;85:817-27.
2. Boldin MP, Goncharov TM, Goltsev YV, Wallach D. Involvement of MACH a novel MORT1/FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death. Cell 1996;85:803-15.
3. LeBlanc HN, Ashkenazi A. Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ 2003;10:66-75.
4. Peter ME, Krummer PH. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ 2003;10:26-35.
5. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med 2000;6:513-9.
6. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME. Two CD95 (APO-1/Fas) signaling pathways. EMBO J 1998;17:1675-87.
7. Los M, Wesselborg S, Schulze-Osthoff K. The role of caspases in development, immunity, and apoptotic signal transduction: lessons from knockout mice. Immunity 1999;10:629-39.
8. Teitz T, Wei T, Valentine MB, Vanin EF, Grenet J, Valentine VA, Behm FG, Look AT, Lahti JM, Kidd VJ. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 2000;6:529-35.
9. Schimmer AD, Pedersen IM, Kitada S, Eks ioglu-Demiralp E, Minden MD, Pinto R, Mah K, Andreeff M, Kim Y, Suh WS, Reed JC. Functional blocks in caspase activation pathways are common in leukemia and predict patient response to induction chemotherapy. Cancer Res 2003;63:1242-8.
10. Planey SL, Abrams MT, Robertson NM, Litwaek G. Role of apical caspases and glucocorticoid-regulated genes in glucocorticoid-induced apoptosis of pre-B leukemic cells. Cancer Res 2003;63:172-8.
11. Eggert A, Grotzer MA, Zuzak TJ, Wiewrodt BR, Ho R, Ikegaki N, Ikegaki N, Brodeur GM. Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression. Cancer Res 2001;61:1314-19.
12. Fulda S, Kufer MU, Meyer E, van Valen F, Dockhorn-Dworniczak B, Debatin KM. Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer Oncogene 2001;20:5865-77.
13. Muhlethaler-Mottet A, Bourloud KB, Auderset K, Joseph JM, Gross N. Drug-mediated sensitization to TRAIL-induced apoptosis in caspase-8-complemented neuroblastoma cells proceeds via activation of intrinsic and extrinsic pathways and caspase-dependent cleavage of XIAP, Bcl-xL and RIP. Oncogene 2004;23:5415-25.
14. Annicchiarico-Petruzzelli M, Bernassola F, Lovat PE, Redfern CP, Pearson AD, Melino G. Apoptosis in neuroblastomas induced by interferon-γ involves the CD95/CD95L pathway. Med Pediatr Oncol 2001;36:115-17.
15. Fulda S, Debatin KM. IFNγ sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway. Oncogene 2002;21:2295-308.
16. Yang X, Merchant MS, Romero ME, Tsokos M, Wexler LH, Kontny U, Mackall CL, Thiele CJ. Induction of caspase 8 by interferon-γ renders some neuroblastoma (NB) cells sensitive to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but reveals that a lack of membrane TR1/TR2 also contributes to TRAIL resistance in NB. Cancer Res 2003;63:1122-9.
17. Banelli B, Casciano I, Croce M, Di Vinci A, Gelvi I, Pagnan G, Brignole C, Allemanni G, Ferrini S, Ponzoni M, Romani M. Expression and methylation of CASP8 in neuroblastoma: identification of a promoter region. Nat Med 2002;8:1333-5.
18. Casciano I, De Ambrosis A, Croce M, Pagnan G, Di Vinci A, Allemanni G, Banelli B, Ponzoni M, Romani M, Ferrini S. Expression of the caspase-8 gene in neuroblastoma cells is regulated through an essential interferon-sensitive response element (ISRE). Cell Death Differ 2004;11:131-4.
19. Ramana CV, Chatterjee-Kishore M, Nguyen H, Stark GR. Complex roles of Stat1 in regulating gene expression. Oncogene 2000;19:2619-27.
20. Decker T, Kovarik P, Meinke A. GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. J Interferon Cytokine Res 1997;17:121-34.
21. Rein T, Muller M, Zorbas H. In vivo footprinting of the IRF-1 promoter: inducible occupation of a GAS element next to a persistent structural alteration of the DNA. Nucleic Acids Res 1994;11:3033-7.
22. Storm van's Gravesande K, Layne MD, Ye Q, Le L, Baron RM, Perrella MA, Santambrogio L, Silverman ES, Riese RJ. IFN regulatory factor-1 regulates IFN-γ-dependent cathepsin S expression. J Immunol 2002;168:4488-94.
23. Tanaka N, Kawakami T, Taniguchi T. Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol Cell Biol 1993;13:4531-8.
24. Massa PT, Wu H. Interferon regulatory factor element and interferon regulatory factor 1 in the induction of major histocompatibility complex class 1 genes in neural cells. J Interferon Cytokine Res 1995;15:799-810.
25. Ruiz-Ruiz C, Ruiz de Almodovar C, Rodriguez A, Ortiz-Ferron G, Redondo JM, Lopez-Rivas A. The up-regulation of human caspase-8 by interferon-γ in breast tumor cells requires the induction and action of the transcription factor interferon regulatory factor-1. J Biol Chem 2004;279:19712-20.
26. Corrias MV, Occhino M, Croce M, De Ambrosis A, Pistillo MP, Bocca P, Pistoia V, Ferrini S. Lack of HLA-class I antigens in human neuroblastoma cells: analysis of its relationship to TAP and tapasin expression. Tissue Antigens 2001;57:110-17.
27. Boyd KE, Wells J, Gutman J, Bartley SM, Farnham PJ. c-Myc target gene specificity is determined by a post-DNA binding mechanism. Proc Natl Acad Sci USA 1998;95:13887-92.
28. Sciortino S, Gurtner A, Manni I, Fontemaggi G, Dey A, Sacchi A, Ozato K, Piaggio G. The cyclin B1 gene is actively transcribed during mitosis in HeLa cells. EMBO Rep 2001;2:1018-23.
29. Clarke N, Jimenez-Lara AM, Voltz E, Gronemeyer H. Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL. EMBO J 2004;23:3051-60.
30. Oshima S, Nakamura T, Namiki S, Okada E, Tsuchiya K, Okamoto R, Yamazaki M, Yokota T, Aida M, Yamaguchi Y, Kanai T, Handa H et al. Interferon regulatory factor 1 (IRF-1) and IRF-2 distinctively up-regulate gene expression and production of interleukin-7 in human intestinal epithelial cells. Mol Cell Biol 2004;24:6298-310.
31. Mantovani R. The molecular biology of the CCAAT-binding factor NF-Y. Gene 1999;239:15-27.
32. Watanabe N, Sakakibara J, Hovanessian AG, Taniguchi T, Fujita T. Activation of IFN-β element by IRF-1 requires a posttranslational event in addition to IRF-1 synthesis. Nucleic Acids Res 1991;19:4421-28.
33. Liedtke C, Groger N, Manns MP, Trautwein C. The human caspase-8 promoter sustains basal activity through. SP1 and ETS-like transcription factors and can be up-regulated by a p53-dependent mechanism. J Biol Chem 2003;278:27593-604.
34. Falvo JV, Thanos D Maniatis T. Reversal of intrinsic DNA bends in the IFN β gene enhancer by transcription factors and the architectural protein HMG 1(Y). Cell 1995;83:1101-11.
35. Thanos D, Maniatis T. Virus induction of human IFN β gene expression requires the assembly of an enhanceosome. Cell 1995;83:1091-100.
36. Herrmann F, Trowsdale J, Huber C, Seliger B. Cloning and functional analyses of the mouse tapasin promoter. Immunogenetics 2003;55:379-88.
37. Gobin SJ, Biesta P, Van den Elsen PJ. Regulation of human β 2-microglobulin transactivation in hematopoietic cells. Blood 2003;101:3058-64.
38. Gongora C, Degols G, Espert L, Hua TD Mechti N. A unique ISRE, in the TATA-less human Isg20 promoter, confers IRF-1-mediated responsiveness to both interferon type I and type II. Nucleic Acids Res 2000;28:2333-41.
39. Xi H, Blanck G. The IRF-2 DNA binding domain facilitates the activation of the class II transactivator (CIITA) type IV promoter by IRF-I. Mol Immunol 2003;39:677-84.
40. Blanco JC, Contursi C, Salkowski CA, DeWitt DL, Ozato K, Vogel SN. Interferon regulatory factor (IRF)-1 and IRF-2 regulate interferon γ-dependent cyclooxygenase 2 expression. J Exp Med 2000;191:2131-44.
41. Taniguchi T, Ogasawara K, Takaoka A, Tanaka N. IRF family of transcription factors as regulators of host defense. Annu Rev Immunol 2001;19:623-55.
42. Coccia EM, Del Russo N, Stellacci E, Orsatti R, Benedetti E, Marziali G, Hiscott J, Battistini A. Activation and repression of the 2-5A synthetase and p21 gene promoters by IRF-1 and IRF-2. Oncogene 1999;18:2129-37.
43. Jesse TL, LaChance R, Iademarco MF, Dean DC. Interferon regulatory factor-2 is a transcriptional activator in muscle where it regulates expression of vascular cell adhesion molecule-1. J Cell Biol 1998;140:1265-76.
44. Schaefer BC, Paulson E, Strominger JL, Speck SH, Constitutive activation of Epstein-Barr virus (EBV) nuclear antigen I gene transcription by IRF1 and IRF2 durinc restricted EBV latency. Mol Cell Biol 1997;17:873-86.
45. Vaughan PS, Aziz F, van Wijnen AJ, Wu S, Harada H, Taniguchi T, Soprano KJ, Stein JL, Stein GS. Activation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2. Nature 1995;377:362-5.
46. Vaughan PS, van der Meijden CM, Aziz F, Harada H, Taniguchi T, van Wijnen AJ, Stein JL, Stein GS. Cell cycle regulation of histone 114 gene transcription requires the oncogenic factor IRF-2. J Biol Chem 1998;273:194-9.
47. Luo W, Skalnik DG. Interferon regulatory factor-2 directs transcription from the gp91phox promoter J Biol Chem 1996;271:23445-51.
48. Fernandes-Alnemri T, Armstrong RC, Krebs J, Srinivasula SM, Wang L, Bullrich F, Fritz LC, Trapani JA, Tomaselli KJ, Litwack G, Alnemri ES. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc Natl Acad Sci USA 1996;93:7464-9.
49. Himeji D, Horiuchi T, Tsukamoto H, Hayashi K, Watanabe T, Harada M. Characterization of caspase-8L: a novel isoform of caspase-8 that behaves as an inhibitor of the caspase cascade. Blood 2002;99:4070-8.